Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 41Thoracic 4Head & Neck 4Gynecologic 4Genitourinary 2Dermatologic 1CNS 1Breast 1

Conditions

Neuroblastoma 55Central Nervous System Neoplasms 53Brain Neoplasms 48Astrocytoma 30Glioblastoma 27Medulloblastoma 25Glioma 23Oligodendroglioma 21Gliosarcoma 14Optic Nerve Glioma 13Testicular Neoplasms 11Choroid Plexus Neoplasms 11Sarcoma 10Ovarian Neoplasms 10Neoplasms 10Rhabdoid Tumor 9Carcinoma, Non-Small-Cell Lung 9Testicular Germ Cell Tumor 7Teratoma 7Recurrence 7Neuroectodermal Tumors, Primitive, Peripheral 7Familial ependymoma 7Ependymoma 7Lung Neoplasms 6Spinal Cord Neoplasms 5Retinoblastoma 5Osteosarcoma 5Neuroectodermal Tumors, Primitive 5Lymphoma 5Liver Neoplasms 5

Interventions

regorafenib 2Nivolumab 2pembrolizumab 1aflibercept 1adavosertib 1Radiotherapy 1Radiation 1Paclitaxel 1NEO212 1Ipilimumab 1IFL protocol 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Carboplatin × CNS × Clear all
NCT06047379 2026-03-02

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Neonc Technologies, Inc.

Phase 1/2 Recruiting
134 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Astrocytoma, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Glioblastoma, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Central Nervous System Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡